SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

BioMarin Pharmaceutical Inc. (BMRN)

BMRN RSS Feed
Add BMRN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 8/25/2016 11:56:12 AM - Followers: 11 - Board type: Free - Posts Today: 0

http://www.bmrn.com/

http://finance.yahoo.com/q/ks?s=BMRN

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions. Its product portfolio comprises approved products and multiple investigational product candidates. The company?s approved products include Naglazyme (galsulfase), a recombinant form of N-acetylgalactosamine 4-sulfatase enzyme used to treat genetic disease called mucopolysaccharidosis (MPS)VI; Kuvan (sapropterin dihydrochloride), a proprietary synthetic oral form of 6R-BH4, a naturally occurring enzyme co-factor for phenylalanine hydroxylase indicated for patients with Phenylketonuria (PKU); and Aldurazyme (laronidase) that is used to treat mucopolysaccharidosis I caused by the deficiency of a lysosomal enzyme called alpha-L-iduronidase. Its clinical development products comprise various product candidates for the treatment of genetic diseases, which include PEG-PAL, an enzyme substitution therapy under Phase I clinical development to treat phenylketonurics, which are not responsive to Kuvan; 6R-BH4, a Phase II clinical development product for the treatment of multiple cardiovascular indications, including sickle cell disease; and GALNS, an enzyme replacement therapy for MPS Type IV or Morquio Syndrome Type A (MPS IV A), a lysosomal storage disease. In addition, the company is conducting preclinical development of various other enzyme product candidates for genetic and other diseases, including a small molecule for the treatment of Duchenne muscular dystrophy. Further, BioMarin holds rights to receive royalties related to Orapred and Orapred ODT as a result of sublicense of North American rights. The company sells its products to specialty pharmacies, hospitals acting as retailers, and pharmaceutical wholesalers in the United States, Europe, and internationally. It has a strategic alliance with Merck Serono S.A. and joint venture with Genzyme Corporation. The company was founded in 1996 and is headquartered in Novato, California.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMRN
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BMRN News: BioMarin Reviews Status of Exon 51 Composition of Matter and Method of Use Patent Interference Cases against Sarepta Therapeu... 09/21/2016 08:54:21 AM
BMRN News: Statement of Changes in Beneficial Ownership (4) 09/19/2016 06:43:01 PM
BMRN News: BioMarin Announces EMA Validation of Brineura™ (Cerliponase Alfa) Marketing Authorization Application for Treatment of CLN2... 09/15/2016 08:38:20 AM
BMRN News: BioMarin Announces Two Oral and 16 Poster Presentations at Society for the Study of Inborn Errors of Metabolism 2016 Annual M... 09/08/2016 04:30:00 AM
BMRN News: BioMarin Announces Update to Brineura™ (Cerliponase Alfa) Program for Treatment of CLN2 Disease, a Form of Batten Disease 09/06/2016 04:05:00 PM
PostSubject
#667   Always good to see the bulls. K The New Investor 08/25/16 11:56:12 AM
#666   BMRN bullish 91.99 stocktrademan 08/19/16 04:12:47 PM
#665   FDA denied BMRN. SRPT is leading now. IPO$ 08/11/16 10:28:30 AM
#664   BioMarin, Sarepta’s Loss Could Be PTC Therapeutic’s Gain venturecapp 01/18/16 12:12:48 PM
#663   Could the FDA Approve Both BioMarin and Sarepta’s trendmkr 12/17/15 02:09:43 PM
#662   Two Stocks to Watch This Month in Biotech trendmkr 12/03/15 01:28:09 PM
#661   Surprised to see you here. Bio-Marin is heading AliEn BRaInZ stox 11/29/15 12:15:11 PM
#660   Looks like we're all going to be on sunspotter 11/24/15 07:30:31 AM
#659   BMRN W TREND1 07/22/15 03:48:10 PM
#658   Inst % Owned = 99% TREND1 07/17/15 01:10:51 PM
#657   Now in regards to this, I would think KingDMC 07/17/15 10:40:15 AM
#656   Thank you KingDMC 07/17/15 10:39:33 AM
#655   King I think you are one of the TREND1 07/17/15 08:58:53 AM
#654   You'll find that I'm not a dumb retail KingDMC 07/17/15 08:50:45 AM
#653   KING Interesting how we find the same stocks. TREND1 07/16/15 11:07:58 PM
#652   BMRN W TREND1 07/16/15 11:06:00 PM
#651   Deutsche, Jeffries, Barclays $156 PT this morning. KingDMC 06/18/15 09:12:09 AM
#650   $BMRN DD Notes ~ http://www.ddnotesmaker.com/BMRN stocktrademan 09/26/14 01:48:57 PM
#649   Don't have PM and haven't been following BioMarin chmcnfunds 07/30/14 10:41:36 AM
#648   Great company. If you are in over the chmcnfunds 02/18/14 08:59:42 AM
#647   BioMarin Announces FDA Approval for VIMIZIM(TM) (elosulfase alfa) [SMART MONEY] 02/17/14 06:34:49 AM
#646   Not that I believe the BMRN drug would ghmm 01/02/14 06:21:15 PM
#645   Direct link to the briefing materials: chmcnfunds 11/15/13 10:00:57 AM
#644   FDA Posts Briefing Documents for Advisory Committee Meeting chmcnfunds 11/15/13 09:39:34 AM
#643   BioMarin Announces French ATU Granted for Vimizim(TM) for chmcnfunds 11/15/13 08:32:12 AM
#642   MACD crosses over and SAR flips today: chmcnfunds 11/13/13 10:22:56 AM
#641   Discussion in recent increase in shorts: chmcnfunds 11/13/13 07:33:27 AM
#640   Whomever purchased the big block is currently down chmcnfunds 11/12/13 11:32:39 AM
#639   AstraZeneca added 14p to £32.92 as it announced chmcnfunds 11/12/13 10:03:29 AM
#638   400,000 share purchase just made @ $62.00 (8:31:58 chmcnfunds 11/12/13 08:51:49 AM
#637   Thanks -- great find. Need a moderator to chmcnfunds 11/11/13 03:25:08 PM
#636   It looks like there will be a free ghmm 11/11/13 02:47:54 PM
#635   ghmm, I haven't seen anything about a webcast. chmcnfunds 11/11/13 02:41:39 PM
#634   Do you (or anyone) know if their will ghmm 11/11/13 01:53:11 PM
#633   A little over a week away: chmcnfunds 11/11/13 01:51:14 PM
#632   BioMarin Begins Phase 3 Trial Of BMN 673 chmcnfunds 10/31/13 11:42:30 AM
#631   From Sheff: chmcnfunds 10/29/13 03:10:23 PM
#630   Biotechs With FDA Review Dates In November 2013 chmcnfunds 10/25/13 02:00:23 PM
#629   Sell-side adjusts BioMarin targets after earnings • 11:15 AM chmcnfunds 10/25/13 01:15:16 PM
#628   Roche talks rare diseases, won't comment on Alexion, chmcnfunds 10/23/13 11:57:47 AM
#627   Roche talks rare diseases, won't comment on Alexion, chmcnfunds 10/23/13 11:57:47 AM
#626   Nice article on JJ/the company ghmm 10/23/13 09:16:37 AM
#625   BioMarin Surges on Report Roche Is Seeking Bid Financing surf1944 09/19/13 08:46:34 AM
#624   Yes, a lot of love passed out by $A-Train 09/18/13 10:57:14 AM
#623   Cramer just told everyone to buy - RIGHT gixxer11 09/17/13 06:33:51 PM
#622   SHAREHOLDERS, WRITE THIS COMPANY AND DEMAND THEY HELP es1 09/13/13 10:45:40 AM
#621   Q2 Earnings ECole 08/06/13 04:59:02 AM
#620   Goldman-Sachs Healthcare-Conference ECole 07/16/13 10:24:09 AM
#619   They did a PR much later then I iwfal 05/17/13 01:13:32 AM
#618   They did a PR much later then I ghmm 05/16/13 06:42:24 PM
PostSubject